📋 Tender Overview
The service in this bidding requires implementing the Obesity Approach strategy, which includes the delivery of the medication Semaglutide in 4 injectable presentations approved by the ISP for use in Obesity, for use in APS, with partial deliveries in 2026 and April 2027.
